Artios Raises 115M for DDR Trials, Microclots Reveal Long COVID Clues, Genetic Key Alters Seasonal Mammal Behavior, Star Beyond Solar System Ejects CME, and more...

(0:10): Artios Pharma Raises $115M to Boost DDR Cancer Pipeline with Promising New Trials(2:15): Study Reveals Microclots and NETs as Key Biomarkers for Diagnosing Long COVID(4:01): Breakthrough: Genetic Key to Seasonal Behavior in Mammals Unlocked by New Study(5:47): First Ever Coronal Mass Ejection Detected from Star Beyond Solar System, Impacts Exoplanet Habitability(7:32): BioRestorative's BRTX-100 Gains FDA Fast Track: Aims for Accelerated Phase 3 Trial for Back Pain TherapyTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: COINTURK FINANCE